山东大学学报 (医学版) ›› 2026, Vol. 64 ›› Issue (1): 37-42.doi: 10.6040/j.issn.1671-7554.0.2025.0229
• 重点专题——精神与睡眠问题的机制证据与转化 • 上一篇 下一篇
周朝雄,付屹
ZHOU Chaoxiong, FU Yi
摘要: 目的 探讨血清甲状腺素(thyroxine, T4)、三碘甲状腺原氨酸(triiodothyronine, T3)、皮质醇(cortisol, Cor)水平与双相情感障碍(bipolar disorder, BD)患者自知力的关系,分析其对患者攻击行为的预测价值。 方法 选取江西省精神病院2021年6月至2024年6月收治的184例 BD 患者,按有无攻击行为分为攻击行为组(71 例)和非攻击行为组(113 例),另选同期70名健康者作对照组。检测血清 T4、T3、Cor 水平;采用自知力与治疗态度问卷(insight and treatment attitudes questionnaires, ITAQ)评估患者自知力。采用Pearson相关分析 BD 患者血清 T4、T3、Cor 水平与自知力的相关性;采用 logistic 回归分析 BD 患者发生攻击行为的危险因素,通过受试者工作特征(receiver operating characteristic, ROC)曲线分析血清 T4、T3、Cor 水平对 BD 患者发生攻击行为的预测价值。 结果 攻击行为组血清T4、T3、Cor水平高于非攻击行为组,ITAQ 评分低于非攻击行为组,差异有统计学意义(P<0.05)。BD 患者血清T4、T3、Cor水平与自知力呈负相关(r=-0.443、-0.364、-0.461,P<0.001)。血清T4(OR=1.192, 95%CI=1.052~1.352)、T3(OR=1.177, 95%CI=1.036~1.337)、Cor 水平(OR=1.196, 95%CI=1.059~1.351)、婚姻状况(OR=1.175, 95%CI=1.010~1.366)、应激事件(OR=1.183, 95%CI=1.043~1.341)是 BD 患者发生攻击行为的危险因素,ITAQ评分(OR=0.781, 95%CI=0.663~0. 921)与攻击行为的发生风险呈负相关(P<0.05)。血清 T4、Cor 水平预测攻击行为的 AUC 分别为 0.755、0.725。 结论 血清 T4、T3、Cor 水平与 BD 患者自知力呈负相关,血清 T4、Cor 水平对 BD 患者发生攻击行为有一定预测价值。
中图分类号:
| [1] Keramatian K, Chakrabarty T, Saraf G, et al. Transitioning to bipolar disorder: a systematic review of prospective high-risk studies[J]. Curr Opin Psychiatry, 2022, 35(1): 10-21. [2] Nierenberg AA, Agustini B, Köhler-Forsberg O, et al. Diagnosis and treatment of bipolar disorder: a review[J]. JAMA, 2023, 330(14): 1370-1380. [3] Liu SS, Chen XA, Li XT, et al. Thyroid hormone levels in patients with bipolar disorder: a systematic review and meta-analysis[J]. BMC Endocr Disord, 2024, 24(1): 248. doi: 10.1186/s12902-024-01776-1 [4] Tohumcu K, Çuhadar D. The relationship between insight and coping attitudes in bipolar disorder patients[J]. Psychol Health Med, 2025, 30(1): 1-18. [5] 王西林, 杨婵娟, 程道猛. 双相情感障碍患者攻击行为的列线图预测模型构建[J]. 实用医学杂志, 2024, 40(5): 677-681. WANG Xilin, YANG Chanjuan, CHENG Daomeng. Construction of a nomogram prediction model for aggre-ssive behavior in patients with bipolar disorder[J]. The Journal of Practical Medicine, 2024, 40(5): 677-681. [6] 沈小琴, 张丞, 刘若楠. 双相情感障碍患者内分泌代谢状况与冲动攻击行为的相关性[J]. 神经疾病与精神卫生, 2021, 21(1): 15-20. SHEN Xiaoqin, ZHANG Cheng, LIU Ruonan. Correlation between endocrine metabolism and impulsive aggre-ssive behavior in patients with bipolar disorder[J]. Journal of Neuroscience and Mental Health, 2021, 21(1): 15-20. [7] Van Uytfanghe K, Ehrenkranz J, Halsall D, et al. Thyroid stimulating hormone and thyroid hormones(triiodothyronine and thyroxine): an American thyroid association-commissioned review of current clinical and laboratory status[J]. Thyroid, 2023, 33(9): 1013-1028. [8] 陈雪凝, 吴丽娜, 陈盛柏. 双相情感障碍躁狂发作患者血清甲状腺激素、性激素、多巴胺水平与其攻击行为相关性分析[J]. 中华保健医学杂志, 2023, 25(4): 470-472. CHEN Xuening, WU Lina, CHEN Shengbai. Correlation analysis between serum thyroid hormone, sex hormone and dopamine levels and aggressive behavior in patients with bipolar disorder manic episode[J]. Chinese Journal of Health Care and Medicine, 2023, 25(4): 470-472. [9] Messent P. DSM-5[J]. Clinical child psychology and psychiatry, 2013, 18(4): 479-482. [10] 黄俭, 程小伟, 朱向阳, 等. 科拉奇分析法联合认知行为疗法在青少年非自杀性自伤行为中的应用及其对Barratt评分和MOAS的影响[J]. 实用医学杂志, 2022, 38(3): 360-365. HUANG Jian, CHENG Xiaowei, ZHU Xiangyang, et al. Colaizzi analysis combined with cognitive-behavior therapy for adolescent non-suicidal self-injury and its effect on Barratt score and MOAS[J]. The Journal of Practical Medicine, 2022, 38(3): 360-365. [11] Meule A. Sorting the confusion about the numerous versions of the barratt impulsiveness scale[J]. Neurol Sci, 2023, 44(10): 3721-3722. [12] 邢字航. 基于DRD4基因遗传多态性和临床资料构建精神分裂症患者攻击行为预测模型[J]. 精神医学杂志, 2023, 36(1): 47-52. XING Zihang. A prediction model of aggressive behavior in schizophrenics based on genetic polymorphism of DRD4 gene and clinical data[J]. Journal of Psychiatry, 2023, 36(1): 47-52. [13] 王博, 梁鑫浩, 安宁宁, 等. 积极应对方式在首发未治疗精神分裂症患者疾病严重程度与自知力和治疗态度间的中介作用[J]. 中国医药导报, 2024, 21(23): 132-135. WANG Bo, LIANG Xinhao, AN Ningning, et al. Mediating effect of positive coping style on disease severity, self-awareness and treatment attitude in patients with first-episode untreated schizophrenia[J]. China Medical Herald, 2024, 21(23): 132-135. [14] Bauer MS. Bipolar disorder[J]. Ann Intern Med, 2022, 175(7): ITC97-ITC112. [15] Malhi GS, Jadidi M, Bell E. The diagnosis of bipolar disorder in children and adolescents: past, present and future[J]. Bipolar Disord, 2023, 25(6): 469-477. [16] Scott K, Nunes A, Pavlova B, et al. Familial traits of bipolar disorder: a systematic review and meta-analysis[J]. Acta Psychiatr Scand, 2023, 148(2): 133-141. [17] Chakrabarty T, Frangou S, Torres IJ, et al. Brain age and cognitive functioning in first-episode bipolar disorder[J]. Psychol Med, 2023, 53(11): 5127-5135. [18] Madireddy S, Madireddy S. Therapeutic interventions to mitigate mitochondrial dysfunction and oxidative stress-induced damage in patients with bipolar disorder[J]. Int J Mol Sci, 2022, 23(3): 1844. doi: 10.3390/ijms23031844 [19] Liu SS, Chen XA, Li XT, et al. Thyroid hormone levels in patients with bipolar disorder: a systematic review and meta-analysis[J]. BMC Endocr Disord, 2024, 24(1): 248. doi: 10.1186/s12902-024-01776-1 [20] Lyu N, Zhao Q, Fu BB, et al. Hormonal and inflammatory signatures of different mood episodes in bipolar disorder: a large-scale clinical study[J]. BMC Psychiatry, 2023, 23(1): 449. doi: 10.1186/s12888-023-04846-1 [21] Salas-Lucia F, Bianco AC. T3 levels and thyroid hormone signaling[J]. Front Endocrinol(Lausanne), 2022, 13: 1044691. doi: 10.3389/fendo.2022.1044691 [22] Wang SX, Chen MX, Sun DQ, et al. Total triiodothyronine level associated with disease severity for patients with emergent status[J]. Sci Rep, 2024, 14(1): 17170. doi: 10.1038/s41598-024-68195-z [23] De Almeida R, McCalmon S, Cabandugama PK. Clinical review and update on the management of thyroid storm[J]. Mo Med, 2022, 119(4): 366-371. [24] Wang X, Luo J, Yuan XF, et al. Relationship of free thyroxine and triiodothyronine on recurrence in maintenance therapy for bipolar depression[J]. Asian J Psychiatr, 2022, 71: 103086. doi: 10.1016/j.ajp.2022.103086 [25] Hochbaum DR, Hulshof L, Urke A, et al. Thyroid hormone remodels cortex to coordinate body-wide metabolism and exploration[J]. Cell, 2024, 187(20): 5679-5697. |
| [1] | 张小艳 李刚 王令平. 不同剂量舒芬太尼对脊柱手术患者全麻诱导期血流动力学及血浆皮质醇的影响[J]. 山东大学学报(医学版), 2209, 47(6): 76-79. |
| [2] | 林雨洋,王蓓,李菲. 大于10 mm甲状腺乳头状癌侧颈区淋巴结转移预测[J]. 山东大学学报 (医学版), 2024, 62(6): 54-64. |
| [3] | 姜震,孙静,邹雯,王唱唱,高琦. 基于两种机器学习算法的双相情感障碍患者自杀行为影响因素模型比较研究[J]. 山东大学学报 (医学版), 2022, 60(1): 101-108. |
| [4] | 王余余,高丽,陈少华. 94例2型糖尿病患者急性脑梗死后认知障碍与甲状腺功能的关联性[J]. 山东大学学报 (医学版), 2020, 58(5): 56-61. |
| [5] | 申妍,左常婷. 济南地区正常妊娠妇女各期甲状腺功能指标的参考值范围评估[J]. 山东大学学报(医学版), 2016, 54(5): 34-38. |
| [6] | 余慧慧, 雷震, 路翠艳, 江虹, 王淑康, 潘芳. 团体心理干预对糖尿病患者心理和生理状况的影响[J]. 山东大学学报(医学版), 2015, 53(5): 89-94. |
| [7] | 朱锡德. 颅脑创伤急诊手术对血清皮质醇的影响[J]. 山东大学学报(医学版), 2014, 52(6): 58-61. |
| [8] | 杨学成1,孙瑞霞2,范靓靓3,王开平2,矫文娟2,曹彩霞2,高燕燕2,孙立江1,王新生1. 类固醇合成酶在亚临床库欣综合征患者中的表达及意义[J]. 山东大学学报(医学版), 2012, 50(12): 87-. |
| [9] | 苏玉玲1,曲莉莉1 ,侯桂华2. 黄芪注射液对同种移植小鼠糖皮质激素受体及移植物生存的影响[J]. 山东大学学报(医学版), 2011, 49(7): 86-. |
| [10] | 王娜,孙正芸,王合丽,林霞,刘彦娥. 妊娠糖尿病母亲新生儿及健康巨大儿血糖、胰岛素和皮质醇水平的变化[J]. 山东大学学报(医学版), 2011, 49(6): 8-. |
| [11] | 刘萌1,鲁燕霞1,江虹1,石寿森2,杨乐金1,刘欣1,张茜1,潘芳1. 音乐治疗对应激哮喘大鼠免疫功能的影响[J]. 山东大学学报(医学版), 2010, 48(1): 56-. |
| [12] | . 喹硫平和阿立哌唑治疗双相情感障碍抑郁发作的疗效及安全性临床试验研究[J]. 山东大学学报(医学版), 2009, 47(8): 118-121. |
| [13] | 张小艳 李刚 王令平. 不同剂量舒芬太尼对脊柱手术患者全麻诱导期血流动力学及血浆皮质醇的影响[J]. 山东大学学报(医学版), 2009, 47(6): 76-79. |
| [14] | 樊淑娟,刘德祥,宋静,江虹,杨乐金,刘欣,潘芳 . 抗应激处理对慢性应激大鼠行为、血清IL-6和皮质醇的影响[J]. 山东大学学报(医学版), 2008, 46(1): 60-63. |
|
||